[HTML][HTML] MR-guided hypofractionated radiotherapy: current emerging data and promising perspectives for localized prostate cancer

…, ML Bonų, R Ruggieri, M Buglione di Monale e Bastia… - Cancers, 2021 - mdpi.com
Simple Summary The biological features of prostate cancer as a tumor with a low alpha beta
ratio have led clinicians to consider the use of higher doses per fraction, thus gaining an …

[HTML][HTML] Home-based pulmonary rehabilitation in patients undergoing (chemo) radiation therapy for unresectable lung cancer: A prospective explorative study

…, A Borghesi, M Buglione di Monale e Bastia… - La radiologia …, 2022 - Springer
… distance in 6MWT, however, the result of this study (an increase of 56.6 m) is significant
either for the definition suggested by Holland and Granger of 25 m and 42 m, respectively [32]33. …

Correlation between human papillomavirus status and quantitative MR imaging parameters including diffusion-weighted imaging and texture features in …

…, GM Agazzi, MBM e Bastia… - American Journal …, 2018 - Am Soc Neuroradiology
BACKGROUND AND PURPOSE: The incidence of Oropharyngeal Squampus Cell Carcinoma
(OPSCC) cases is increasing especially in the Western countries due to the spreading of …

Brain metastases from primary colorectal cancer: is radiosurgery an effective treatment approach? Results of a multicenter study of the radiation and clinical oncology …

…, M Buglione di Monale e Bastia… - The British Journal of …, 2020 - academic.oup.com
Buglione di Monale e Bastia, Sara Pedretti, Alessio Bruni, Isa Bossi Zanetti, Simona
Borghesi, Fabio Busato, Francesco Pasqualetti, Fabiola Paiar, Marta Scorsetti, Brain metastases …

[HTML][HTML] Unresectable stage III non-small cell lung cancer: could durvalumab be safe and effective in real-life clinical scenarios? Results of a single-center experience

…, S Grisanti, M Buglione di Monale e Bastia - Frontiers in …, 2023 - frontiersin.org
Buglione di Monale e Bastia. This is an open-access article distributed under the terms of
the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in …

Stereotactic radiotherapy with simultaneous integrated protection planning technique for synovial sarcoma with stomach abutment: A case report of a complete …

…, D Tomasini, M BUGLIONE DI MONALE E BASTIA… - Tumor …, 2023 - iris.unibs.it
Here, we report the clinical case of a 44-year-old lady, affected by synovial sarcoma (SS) of
the mediastinum which was treated in 2014, and relapsed in the upper abdomen in 2020. SS …

[HTML][HTML] A Brief Report on the Role of SPECT/TC in the Optimization of Radiotherapy Treatment with Radical Intent for Unresectable Stage III NSCLC

…, F Vaccher, A Guerini, M Buglione di Monale e Bastia… - Applied Sciences, 2022 - mdpi.com
Background: The standard treatment for locally advanced non-small cell lung cancer (LA-NSCLC)
is represented by concomitant chemo-radiotherapy followed by consolidation with …

[HTML][HTML] Short fractionation radiotherapy for early prostate cancer in the time of COVID-19: long-term excellent outcomes from a multicenter Italian trial suggest a larger …

…, MB di Monale E Bastia, M Marcenaro, E Tornari… - La radiologia …, 2021 - Springer
… Barra, S., Guarnieri, A., di Monale e Bastia, MB et al. Short fractionation radiotherapy for
early prostate cancer in the time of COVID-19: long-term excellent outcomes from a multicenter …

[PDF][PDF] Stereotactic Radiation Therapy of Lung Cancers and Subsequent Parenchymal Alterations: from Their Spatial Distribution to the Use in Clinical Practice

…, P Vitali, M BUGLIONE DI MONALE E BASTIA… - Clinics of …, 2020 - iris.unibs.it
1.1. Aims Stereotactic body radiation therapy (SBRT) is one of the standard radical treatments
in stage I nonsmall cell lung cancer (NSCLC) and an option for lung metastases. The …

Dynamic Susceptibility Contrast MR Imaging inGlioblastomas: Correlation of Whole-TumorHistogram Analysis of the Normalized CerebralBlood Volume and Vascular …

…, M BUGLIONE DI MONALE E BASTIA… - … 50th ASNR Annual …, 2012 - iris.unibs.it
PURPOSE To date, molecular subtypes of glioblastoma only can be identified by genetic
analysis of surgical specimens. Aim of the study is to determine whether whole-tumor …